Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

The Genomic Impact of DNA CpG Methylation on Gene Expression; Relationships in Prostate Cancer.

Long MD, Smiraglia DJ, Campbell MJ.

Biomolecules. 2017 Feb 14;7(1). pii: E15. doi: 10.3390/biom7010015. Review.

2.

A polymorphic minisatellite region of BORIS regulates gene expression and its rare variants correlate with lung cancer susceptibility.

Yoon SL, Roh YG, Chu IS, Heo J, Kim SI, Chang H, Kang TH, Chung JW, Koh SS, Larionov V, Leem SH.

Exp Mol Med. 2016 Jul 15;48(7):e246. doi: 10.1038/emm.2016.50.

3.

Comparative analyses of CTCF and BORIS occupancies uncover two distinct classes of CTCF binding genomic regions.

Pugacheva EM, Rivero-Hinojosa S, Espinoza CA, Méndez-Catalá CF, Kang S, Suzuki T, Kosaka-Suzuki N, Robinson S, Nagarajan V, Ye Z, Boukaba A, Rasko JE, Strunnikov AV, Loukinov D, Ren B, Lobanenkov VV.

Genome Biol. 2015 Aug 14;16:161. doi: 10.1186/s13059-015-0736-8.

4.

Expression of the CTCFL Gene during Mouse Embryogenesis Causes Growth Retardation, Postnatal Lethality, and Dysregulation of the Transforming Growth Factor β Pathway.

Sati L, Zeiss C, Yekkala K, Demir R, McGrath J.

Mol Cell Biol. 2015 Oct;35(19):3436-45. doi: 10.1128/MCB.00381-15. Epub 2015 Jul 13.

5.

Frequent disruption of chromodomain helicase DNA-binding protein 8 (CHD8) and functionally associated chromatin regulators in prostate cancer.

Damaschke NA, Yang B, Blute ML Jr, Lin CP, Huang W, Jarrard DF.

Neoplasia. 2014 Dec;16(12):1018-27. doi: 10.1016/j.neo.2014.10.003.

6.

Differential regulation of MAGE-A1 promoter activity by BORIS and Sp1, both interacting with the TATA binding protein.

Schwarzenbach H, Eichelser C, Steinbach B, Tadewaldt J, Pantel K, Lobanenkov V, Loukinov D.

BMC Cancer. 2014 Nov 3;14:796. doi: 10.1186/1471-2407-14-796.

7.

Induction of a specific CD8+ T-cell response to cancer/testis antigens by demethylating pre-treatment against osteosarcoma.

Li B, Zhu X, Sun L, Yuan L, Zhang J, Li H, Ye Z.

Oncotarget. 2014 Nov 15;5(21):10791-802.

8.

High expression of hTERT and stemness genes in BORIS/CTCFL positive cells isolated from embryonic cancer cells.

Alberti L, Renaud S, Losi L, Leyvraz S, Benhattar J.

PLoS One. 2014 Oct 3;9(10):e109921. doi: 10.1371/journal.pone.0109921. eCollection 2014.

9.

Circulating cell-free cancer-testis MAGE-A RNA, BORIS RNA, let-7b and miR-202 in the blood of patients with breast cancer and benign breast diseases.

Joosse SA, Müller V, Steinbach B, Pantel K, Schwarzenbach H.

Br J Cancer. 2014 Aug 26;111(5):909-17. doi: 10.1038/bjc.2014.360. Epub 2014 Jul 1.

10.

Epigenetics of lung cancer.

Langevin SM, Kratzke RA, Kelsey KT.

Transl Res. 2015 Jan;165(1):74-90. doi: 10.1016/j.trsl.2014.03.001. Epub 2014 Mar 12. Review.

11.

A genome-wide gene-environment interaction analysis for tobacco smoke and lung cancer susceptibility.

Zhang R, Chu M, Zhao Y, Wu C, Guo H, Shi Y, Dai J, Wei Y, Jin G, Ma H, Dong J, Yi H, Bai J, Gong J, Sun C, Zhu M, Wu T, Hu Z, Lin D, Shen H, Chen F.

Carcinogenesis. 2014 Jul;35(7):1528-35. doi: 10.1093/carcin/bgu076. Epub 2014 Mar 22.

12.

Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene.

Hoivik EA, Kusonmano K, Halle MK, Berg A, Wik E, Werner HM, Petersen K, Oyan AM, Kalland KH, Krakstad C, Trovik J, Widschwendter M, Salvesen HB.

Oncotarget. 2014 Feb 28;5(4):1052-61.

13.

CTCF and CTCFL mRNA expression in 17β-estradiol-treated MCF7 cells.

Del Campo EP, Márquez JJ, Reyes-Vargas F, Intriago-Ortega MD, Quintanar-Escorza MA, Burciaga-Nava JA, Sifuentes-Alvarez A, Reyes-Romero M.

Biomed Rep. 2014 Jan;2(1):101-104. Epub 2013 Nov 15.

14.

BORIS/CTCFL is an RNA-binding protein that associates with polysomes.

Ogunkolade BW, Jones TA, Aarum J, Szary J, Owen N, Ottaviani D, Mumin MA, Patel S, Pieri CA, Silver AR, Sheer D.

BMC Cell Biol. 2013 Nov 26;14:52. doi: 10.1186/1471-2121-14-52.

15.

Cancer-testis gene expression is associated with the methylenetetrahydrofolate reductase 677 C>T polymorphism in non-small cell lung carcinoma.

Senses KM, Gonen M, Barutcu AR, Kalaylioglu Z, Isbilen M, Konu O, Chen YT, Altorki NK, Gure AO.

BMC Med Genet. 2013 Sep 24;14:97. doi: 10.1186/1471-2350-14-97.

16.

Induced DNA demethylation can reshape chromatin topology at the IGF2-H19 locus.

Ito Y, Nativio R, Murrell A.

Nucleic Acids Res. 2013 May 1;41(10):5290-302. doi: 10.1093/nar/gkt240. Epub 2013 Apr 12.

17.

BORIS/CTCFL mRNA isoform expression and epigenetic regulation in epithelial ovarian cancer.

Link PA, Zhang W, Odunsi K, Karpf AR.

Cancer Immun. 2013;13:6. Epub 2013 Jan 22.

18.

BORIS, brother of the regulator of imprinted sites, is aberrantly expressed in hepatocellular carcinoma.

Chen K, Huang W, Huang B, Wei Y, Li B, Ge Y, Qin Y.

Genet Test Mol Biomarkers. 2013 Feb;17(2):160-5. doi: 10.1089/gtmb.2012.0242. Epub 2012 Dec 13.

19.
20.

Dose-dependent activation of putative oncogene SBSN by BORIS.

Gaykalova D, Vatapalli R, Glazer CA, Bhan S, Shao C, Sidransky D, Ha PK, Califano JA.

PLoS One. 2012;7(7):e40389. doi: 10.1371/journal.pone.0040389. Epub 2012 Jul 5.

Supplemental Content

Support Center